Among them, PTX inhibited SETDB1 expression in a p53-dependent manner, while cisplatin and doxorubicin reduced H3K9me3 levels and inhibited tumor growth (Na et al., 2016; Na and Kim, 2018). Here, SETDB1 is linked to neoplasm.